TikTok blocks some peptide searches, but variations still appear

TikTok now returns “no results found” for semaglutide and BPC-157 searches, but slight name variations still surface videos—raising moderation and affiliate risks for health creators.

What happened

On October 20, 2026, The Verge reported that TikTok now returns a “no results found” page for searches for terms like semaglutide, BPC-157, retratutide, and others. The change was described as “easily circumvented blocks” for certain peptides, including semaglutide and TB-500.

Peptides are combinations of amino acids that include substances like insulin and GLP-1. The concern is that peptides also include unregulated, unapproved substances that proponents like RFK Jr. say can assist with everything from weight loss to wound healing, despite a lack of clinical data supporting such claims.

Bryan Johnson-connected influencer Jeff Tang alerted people about the apparent TikTok changes in a tweet last night, then posted a video pointing blame at Eli Lilly. TikTok’s US owner did not respond immediately when asked for comment by The Verge. For now, searching “peptides” still pulls up plenty of short videos, and there’s no sign that actual videos have been removed.

Key facts

• TikTok now shows “no results found” for searches like semaglutide, BPC-157, retratutide, and others.
• Peptides include substances like insulin and GLP-1, but also unregulated, unapproved substances promoted for weight loss and wound healing despite a lack of clinical data.
• Bryan Johnson-connected influencer Jeff Tang posted about the changes in a tweet last night and later blamed Eli Lilly in a video.
• Searching “peptides” still surfaces plenty of short videos; there is no sign actual videos have been removed.
• The two ingredients of the “Wolverine” peptide stack — BPC-157 and TB-500 — aren’t searchable, but slight name variations still surface published videos, and TikTok’s search suggestions offered functional variations before typing was complete.

Our analysis

This appears to be a surface-level keyword suppression, not a removal of peptide content. The fact that exact terms return no results while “peptides” still surfaces plenty of videos—and slight spelling variations still rank—suggests TikTok is limiting discoverability rather than enforcing a full category ban. For creators and health marketers, this is a meaningful shift: existing content may stay live, but organic search traffic for specific product-related terms can drop without a formal policy announcement.

The likely affected groups are wellness creators, affiliate marketers, and brands that rely on influencer campaigns around GLP-1 drugs or experimental recovery stacks. The source notes that an “army of influencer proponents” have suggested affiliated compounding pharmacies and other sources of unknown quality. That creates a dual risk: platform moderation may tighten further, and creators who continue under altered keywords could face health regulatory scrutiny if their content promotes unapproved substances.

Because TikTok’s US owner did not comment, the change remains informal and reversible. But the presence of TikTok’s own search suggestions offering functional variations before a search is complete suggests the platform knows the blocks are easy to bypass—and may close those gaps later.

What it means for operators

• Audit current and planned TikTok posts for peptide-related terms such as semaglutide, BPC-157, and TB-500; if search traffic matters, do not rely on exact keywords alone.
• Monitor whether TikTok formalizes this as a policy. For health and wellness creators, review affiliate pharmacy promotions now, because the source highlights “sources of unknown quality” as a risk area.
• Before launching a campaign, test TikTok search for target terms and note the platform’s own suggested variations—those variations currently surface videos, but they may be blocked next.
• Treat spelling variations as a short-term discovery workaround only; if you manage brand safety or creator partnerships, assess the health regulatory exposure of any peptide content before it scales.